izvor podataka: crosbi
!
Vaccine effectiveness against influenza A and A (H3N2: Results from the 2021-2022 season European I-MOVE primary care multicentre study (CROSBI ID 728366)
Prilog sa skupa u zborniku | sažetak izlaganja sa skupa | međunarodna recenzija
Kissling, Esther ; Pozo, Francisco ; Omokanye, Ajibola ; Martinez-Baz, Ivan ; Buda, Silke ; Nonković, Diana.
Vaccine effectiveness against influenza A and A (H3N2: Results from the 2021-2022 season European I-MOVE primary care multicentre study. 2022. str. 95-96
Podaci o odgovornosti
Kissling, Esther ; Pozo, Francisco ; Omokanye, Ajibola ; Martinez-Baz, Ivan ; Buda, Silke ; Nonković, Diana.
engleski
Vaccine effectiveness against influenza A and A (H3N2: Results from the 2021-2022 season European I-MOVE primary care multicentre study
This 2021-2022 VE against circulating influenza A and A(H3N2) was 31-40% overall and among those aged 18- 64 years.
vaccine effectiveness ; Influenza ; I-MOVE study
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o prilogu
95-96.
2022.
objavljeno
Podaci o matičnoj publikaciji
Podaci o skupu
OPTIONS for the Control of Influenza XI (conference)
predavanje
01.01.2022-01.01.2022
Belfast, United Kingdom
